AI Tokens
Stock Analysis on Net

Becton, Dickinson & Co. (NYSE:BDX)

This company has been moved to the archive! The financial data has not been updated since May 5, 2022.

Return on Capital (ROC)

Microsoft Excel

Return on capital (ROC) is after tax rate of return on net business assets. ROIC is unaffected by changes in interest rates or company debt and equity structure. It measures business productivity performance.


Return on Invested Capital (ROIC)

Becton, Dickinson & Co., ROIC calculation, comparison to benchmarks

Microsoft Excel
Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017 Sep 30, 2016
Selected Financial Data (US$ in millions)
Net operating profit after taxes (NOPAT)1 2,155 991 1,105 570 1,300 717
Invested capital2 45,278 46,312 45,181 47,282 34,655 22,258
Performance Ratio
ROIC3 4.76% 2.14% 2.44% 1.21% 3.75% 3.22%
Benchmarks
ROIC, Competitors4
Abbott Laboratories 11.30% — — — — —
Elevance Health Inc. 11.26% — — — — —
Intuitive Surgical Inc. 37.63% — — — — —
Medtronic PLC 5.59% — — — — —
UnitedHealth Group Inc. 13.51% — — — — —

Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).

1 NOPAT. See details »

2 Invested capital. See details »

3 2021 Calculation
ROIC = 100 × NOPAT ÷ Invested capital
= 100 × 2,155 ÷ 45,278 = 4.76%

4 Click competitor name to see calculations.


The return on invested capital (ROIC) for the period between 2016 and 2021 exhibits significant volatility, characterized by a sharp decline in the middle of the period followed by a strong recovery by 2021. This fluctuation is primarily driven by instability in net operating profit after taxes (NOPAT) occurring against a backdrop of rapidly expanding and then stabilizing invested capital.

Net Operating Profit After Taxes (NOPAT)
NOPAT demonstrated substantial variance throughout the six-year period. After an initial increase from 717 million USD in 2016 to 1,300 million USD in 2017, a significant contraction occurred in 2018, with profit falling to 570 million USD. A recovery followed in 2019 and 2020, culminating in a peak of 2,155 million USD in 2021, marking the highest operating profit in the analyzed timeframe.
Invested Capital
Invested capital experienced a rapid expansion phase between 2016 and 2018, growing from 22,258 million USD to 47,282 million USD. This represents a more than twofold increase in the capital base over two years. Following this growth spurt, the invested capital stabilized, maintaining a range between approximately 45,000 million USD and 46,000 million USD from 2019 through 2021.
Return on Invested Capital (ROIC)
ROIC trended downward as the capital base expanded faster than operating profits, reaching a period low of 1.21% in 2018. The subsequent stabilization of invested capital, combined with the recovery of NOPAT, led to a gradual improvement in the ratio. By September 30, 2021, ROIC reached a period high of 4.76%, indicating an improved efficiency in generating profit from the deployed capital base compared to the previous five years.

The overall analysis suggests that the period from 2016 to 2018 was characterized by aggressive capital deployment which initially diluted the return on investment. However, the convergence of a stable capital base and a significant surge in operating profit in 2021 resulted in a substantial expansion of the ROIC.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Decomposition of ROIC

Becton, Dickinson & Co., decomposition of ROIC

Microsoft Excel
ROIC = OPM1 × TO2 × 1 – CTR3
Sep 30, 2021 4.76% = 13.29% × 0.45 × 80.06%
Sep 30, 2020 2.14% = 8.76% × 0.37 × 66.10%
Sep 30, 2019 2.44% = 10.50% × 0.38 × 60.84%
Sep 30, 2018 1.21% = 11.60% × 0.34 × 30.74%
Sep 30, 2017 3.75% = 11.65% × 0.35 × 92.28%
Sep 30, 2016 3.22% = 11.73% × 0.56 × 48.94%

Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).

1 Operating profit margin (OPM). See calculations »

2 Turnover of capital (TO). See calculations »

3 Effective cash tax rate (CTR). See calculations »


Return on invested capital (ROIC) exhibited significant volatility between 2016 and 2021, reaching a low of 1.21% in 2018 before recovering to a period peak of 4.76% in 2021. The decomposition of this return reveals that fluctuations were driven by shifting operational margins, capital efficiency, and highly variable tax impacts.

Operating Profit Margin (OPM)
Profitability remained relatively stable from 2016 to 2018, maintaining a range between 11.60% and 11.73%. A subsequent contraction occurred, with margins declining to 10.50% in 2019 and reaching a low of 8.76% in 2020. A sharp recovery was observed in 2021, where the margin expanded to 13.29%, the highest level recorded during the period.
Turnover of Capital (TO)
Capital efficiency experienced a significant reduction after 2016, dropping from 0.56 to 0.35 in 2017. This diminished turnover persisted through 2020, fluctuating minimally between 0.34 and 0.38. An upward trend emerged in 2021, with the ratio increasing to 0.45, indicating improved asset productivity in generating revenue.
Effective Cash Tax Rate (1 – CTR)
The after-tax multiplier demonstrated extreme volatility throughout the analyzed timeframe. A peak of 92.28% in 2017 was followed by a sharp decline to 30.74% in 2018. From 2019 onward, a consistent recovery trend was observed, with the value rising to 60.84% in 2019, 66.10% in 2020, and ending at 80.06% in 2021.
Return on Invested Capital (ROIC) Synthesis
The fluctuations in ROIC are a direct result of the interplay between the aforementioned drivers. The trough in 2018 was primarily influenced by the sharp drop in the tax multiplier and low capital turnover. Conversely, the peak in 2021 was supported by the simultaneous optimization of operating margins, an increase in capital turnover, and a favorable tax position.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Operating Profit Margin (OPM)

Becton, Dickinson & Co., OPM calculation, comparison to benchmarks

Microsoft Excel
Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017 Sep 30, 2016
Selected Financial Data (US$ in millions)
Net operating profit after taxes (NOPAT)1 2,155 991 1,105 570 1,300 717
Add: Cash operating taxes2 537 508 711 1,285 109 748
Net operating profit before taxes (NOPBT) 2,691 1,500 1,816 1,855 1,408 1,464
 
Revenues 20,248 17,117 17,290 15,983 12,093 12,483
Profitability Ratio
OPM3 13.29% 8.76% 10.50% 11.60% 11.65% 11.73%
Benchmarks
OPM, Competitors4
Abbott Laboratories 20.37% — — — — —
Elevance Health Inc. 6.58% — — — — —
Intuitive Surgical Inc. 33.56% — — — — —
Medtronic PLC 16.48% — — — — —
UnitedHealth Group Inc. 8.33% — — — — —

Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).

1 NOPAT. See details »

2 Cash operating taxes. See details »

3 2021 Calculation
OPM = 100 × NOPBT ÷ Revenues
= 100 × 2,691 ÷ 20,248 = 13.29%

4 Click competitor name to see calculations.


Between the fiscal years ending September 30, 2016, and September 30, 2021, the organization experienced substantial top-line growth accompanied by a volatile operating margin profile. While revenues trended upward over the six-year period, the efficiency of converting these revenues into operating profit underwent a period of compression before achieving a peak in the final year.

Revenue Growth Trajectory
Revenues increased from US$ 12,483 million in 2016 to US$ 20,248 million in 2021. A significant expansion occurred between 2017 and 2018, with revenues rising from US$ 12,093 million to US$ 15,983 million. Despite a marginal dip in 2020, the growth trend accelerated in 2021, crossing the US$ 20 billion threshold.
Net Operating Profit Before Taxes (NOPBT) Analysis
NOPBT exhibited a non-linear growth pattern, starting at US$ 1,464 million in 2016 and reaching US$ 2,691 million by 2021. A period of instability is observed between 2019 and 2020, where NOPBT fell from US$ 1,816 million to US$ 1,500 million, before recovering sharply in the following year.
Operating Profit Margin (OPM) Dynamics
The operating profit margin showed a steady decline for five consecutive years, falling from 11.73% in 2016 to a trough of 8.76% in 2020. This suggests that operating expenses grew at a faster rate than revenues during this interval. However, a significant recovery occurred in 2021, with the margin expanding to 13.29%, marking the highest efficiency level in the analyzed period and indicating a strong recovery in operational profitability.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Turnover of Capital (TO)

Becton, Dickinson & Co., TO calculation, comparison to benchmarks

Microsoft Excel
Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017 Sep 30, 2016
Selected Financial Data (US$ in millions)
Revenues 20,248 17,117 17,290 15,983 12,093 12,483
Invested capital1 45,278 46,312 45,181 47,282 34,655 22,258
Efficiency Ratio
TO2 0.45 0.37 0.38 0.34 0.35 0.56
Benchmarks
TO, Competitors3
Abbott Laboratories 0.69 — — — — —
Elevance Health Inc. 2.14 — — — — —
Intuitive Surgical Inc. 1.27 — — — — —
Medtronic PLC 0.42 — — — — —
UnitedHealth Group Inc. 2.04 — — — — —

Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).

1 Invested capital. See details »

2 2021 Calculation
TO = Revenues ÷ Invested capital
= 20,248 ÷ 45,278 = 0.45

3 Click competitor name to see calculations.


An analysis of the capital turnover performance from 2016 to 2021 reveals a period of significant capital expansion followed by a phase of operational recovery. The turnover of capital ratio experienced a sharp initial decline before trending upward in the latter years of the period, reflecting a shift in the relationship between asset accumulation and revenue generation.

Revenue Trajectory
Revenues demonstrated an overall upward trend, increasing from 12,483 million US$ in 2016 to 20,248 million US$ in 2021. While there was a minor contraction in 2017 and a plateau in 2020, the overall growth indicates a substantial expansion of the top line over the six-year period.
Invested Capital Dynamics
A rapid increase in invested capital occurred between 2016 and 2018, where the amount grew from 22,258 million US$ to 47,282 million US$. Following this aggressive expansion phase, the invested capital stabilized, fluctuating within a narrow range between 45,181 million US$ and 46,312 million US$ from 2019 through 2021.
Capital Turnover Efficiency
The turnover of capital ratio declined sharply from 0.56 in 2016 to a low of 0.34 in 2018, driven by the fact that invested capital grew at a much faster rate than revenues during this interval. However, a recovery phase is observed from 2019 onward, with the ratio improving to 0.45 by 2021. This recovery suggests that the company began to generate higher sales volumes from its expanded capital base, improving the efficiency of its deployed resources.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Effective Cash Tax Rate (CTR)

Becton, Dickinson & Co., CTR calculation, comparison to benchmarks

Microsoft Excel
Sep 30, 2021 Sep 30, 2020 Sep 30, 2019 Sep 30, 2018 Sep 30, 2017 Sep 30, 2016
Selected Financial Data (US$ in millions)
Net operating profit after taxes (NOPAT)1 2,155 991 1,105 570 1,300 717
Add: Cash operating taxes2 537 508 711 1,285 109 748
Net operating profit before taxes (NOPBT) 2,691 1,500 1,816 1,855 1,408 1,464
Tax Rate
CTR3 19.94% 33.90% 39.16% 69.26% 7.72% 51.06%
Benchmarks
CTR, Competitors4
Abbott Laboratories 20.05% — — — — —
Elevance Health Inc. 20.22% — — — — —
Intuitive Surgical Inc. 11.76% — — — — —
Medtronic PLC 18.59% — — — — —
UnitedHealth Group Inc. 20.32% — — — — —

Based on: 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30), 10-K (reporting date: 2016-09-30).

1 NOPAT. See details »

2 Cash operating taxes. See details »

3 2021 Calculation
CTR = 100 × Cash operating taxes ÷ NOPBT
= 100 × 537 ÷ 2,691 = 19.94%

4 Click competitor name to see calculations.


The effective cash tax rate (CTR) exhibited significant volatility between 2016 and 2021, characterized by sharp fluctuations that did not maintain a linear correlation with net operating profit before taxes (NOPBT).

Cash Tax Rate Volatility
An extreme variance in the CTR is observed during the first three years of the period. The rate dropped precipitously from 51.06% in 2016 to a period low of 7.72% in 2017, before surging to a peak of 69.26% in 2018. This instability suggests the influence of non-recurring tax adjustments or significant changes in deferred tax assets and liabilities during those fiscal years.
Recent Downward Trajectory
Following the peak in 2018, a consistent downward trend in the CTR is evident. The rate declined steadily from 69.26% in 2018 to 39.16% in 2019, 33.90% in 2020, and finally to 19.94% in 2021. This suggests a progressive optimization of the cash tax position or the utilization of tax credits over the latter half of the period.
Relationship Between NOPBT and Cash Taxes
A divergence between operating profitability and cash tax payments occurred in 2021. While NOPBT reached a period high of 2,691 million US dollars, the CTR decreased to 19.94%, resulting in cash operating taxes of 537 million US dollars. This represents a significant decoupling compared to 2018, where a lower NOPBT of 1,855 million US dollars was associated with a much higher cash tax outlay of 1,285 million US dollars.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?